US 8580822
Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors
granted A61PA61P21/04A61P25/00
Quick answer
US patent 8580822 (Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors) held by REVIVA PHARMACEUTICALS, INC. expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REVIVA PHARMACEUTICALS, INC.
- Grant date
- Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61P, A61P21/04, A61P25/00, A61P25/02, A61P25/14